These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 28701102)

  • 1. Mechanism of action of mRNA-based vaccines.
    Iavarone C; O'hagan DT; Yu D; Delahaye NF; Ulmer JB
    Expert Rev Vaccines; 2017 Sep; 16(9):871-881. PubMed ID: 28701102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.
    Deering RP; Kommareddy S; Ulmer JB; Brito LA; Geall AJ
    Expert Opin Drug Deliv; 2014 Jun; 11(6):885-99. PubMed ID: 24665982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.
    Kowalczyk A; Doener F; Zanzinger K; Noth J; Baumhof P; Fotin-Mleczek M; Heidenreich R
    Vaccine; 2016 Jul; 34(33):3882-93. PubMed ID: 27269061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and advances towards the rational design of mRNA vaccines.
    Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
    Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Messenger RNA-based vaccines: progress, challenges, applications.
    Kramps T; Probst J
    Wiley Interdiscip Rev RNA; 2013; 4(6):737-49. PubMed ID: 23893949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo.
    Cao Q; Fang H; Tian H
    Biomaterials; 2024 Oct; 310():122628. PubMed ID: 38820767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines 'on demand': science fiction or a future reality.
    Ulmer JB; Mansoura MK; Geall AJ
    Expert Opin Drug Discov; 2015 Feb; 10(2):101-6. PubMed ID: 25582273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-amplifying mRNA vaccines.
    Brito LA; Kommareddy S; Maione D; Uematsu Y; Giovani C; Berlanda Scorza F; Otten GR; Yu D; Mandl CW; Mason PW; Dormitzer PR; Ulmer JB; Geall AJ
    Adv Genet; 2015; 89():179-233. PubMed ID: 25620012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design.
    Pepini T; Pulichino AM; Carsillo T; Carlson AL; Sari-Sarraf F; Ramsauer K; Debasitis JC; Maruggi G; Otten GR; Geall AJ; Yu D; Ulmer JB; Iavarone C
    J Immunol; 2017 May; 198(10):4012-4024. PubMed ID: 28416600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA Vaccine Nanoplatforms and Innate Immunity.
    Wei L; Dong C; Zhu W; Wang BZ
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.
    Linares-Fernández S; Lacroix C; Exposito JY; Verrier B
    Trends Mol Med; 2020 Mar; 26(3):311-323. PubMed ID: 31699497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA Cancer Vaccines-Messages that Prevail.
    Grunwitz C; Kranz LM
    Curr Top Microbiol Immunol; 2017; 405():145-164. PubMed ID: 28401358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity and vaccines.
    Platt A; Wetzler L
    Curr Top Med Chem; 2013; 13(20):2597-608. PubMed ID: 24066890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems integration of innate and adaptive immunity.
    Zak DE; Aderem A
    Vaccine; 2015 Sep; 33(40):5241-8. PubMed ID: 26102534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic mRNA delivery to leukocytes.
    Granot-Matok Y; Kon E; Dammes N; Mechtinger G; Peer D
    J Control Release; 2019 Jul; 305():165-175. PubMed ID: 31121277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity.
    Alter G; Sekaly RP
    Vaccine; 2015 Jun; 33 Suppl 2():B55-9. PubMed ID: 26022570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.
    Minnaert AK; Vanluchene H; Verbeke R; Lentacker I; De Smedt SC; Raemdonck K; Sanders NN; Remaut K
    Adv Drug Deliv Rev; 2021 Sep; 176():113900. PubMed ID: 34324884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
    Maruggi G; Zhang C; Li J; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):757-772. PubMed ID: 30803823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the Adjuvant Activity of RNA Vaccines.
    Pardi N; Weissman D
    Methods Mol Biol; 2017; 1499():143-153. PubMed ID: 27987147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.